12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Wednesday's intraday session, several healthcare stocks experienced significant movements. Werewolf Therapeutics (NASDAQ:HOWL), Reshape Lifesciences (NASDAQ:RSLS), BioXcel Therapeutics (NASDAQ:BTAI), iSpecimen (NASDAQ:ISPC), Titan Pharma (NASDAQ:TTNP), and Catalyst Biosciences (NASDAQ:CBIO) saw their shares rise by 30.0%, 24.06%, 17.94%, 16.66%, 16.5%, and 15.95% respectively. On the other hand, Sonnet BioTherapeutics (NASDAQ:SONN), Motus GI Hldgs (NASDAQ:MOTS), Cibus (NASDAQ:CBUS), DarioHealth (NASDAQ:DRIO), Heart Test Laboratories (NASDAQ:HSCS), and Tharimmune (NASDAQ:THAR) saw their shares decline by 29.6%, 23.65%, 22.94%, 22.34%, 20.63%, and 20.01% respectively.
October 25, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cibus stock declined by 22.94% to $10.65.
The significant decrease in Cibus' share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Motus GI Hldgs shares fell 23.65% to $0.51.
The significant decrease in Motus GI Hldgs' share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Sonnet BioTherapeutics stock declined by 29.6% to $1.27 during Wednesday's regular session.
The significant decrease in Sonnet BioTherapeutics' share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
BioXcel Therapeutics shares rose 17.94% to $2.76.
The significant increase in BioXcel Therapeutics' share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Werewolf Therapeutics shares rose 30.0% to $2.34 during Wednesday's regular session.
The significant increase in Werewolf Therapeutics' share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences stock moved upwards by 24.06% to $0.26.
The significant increase in Reshape Lifesciences' share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100